The Latest Breaking News from melanoma

Stephen Wadey was diagnosed with melanoma seven years ago. After surgery to remove the cancer, he decided to join a clinical trial — despite the huge distance.

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

Scientists have shown for the first time that inhibiting a key metabolic enzyme ‘shows promise’ in killing melanoma cells

Research could lead to a new class of drugs to selectively treat melanoma

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

It is called the ABCDE check and may help you determine if a mole could be cancerous.

Melanoma, or skin cancer, is the one type of cancer that affects more younger people. What major signs should you look out for and how can you check for cancer at home?

When Yvette D'Ath's hairdresser found an unusual mole on her scalp, the Health Minister knew she had to act straight away.

Yorkshire author Hannah Russell, 25, underwent six operations over a two-year period in a bid to beat stage three sarcoma followed by melanoma 12 months later